Company Registration No. 01857555 (England and Wales)
GLEBE CARE LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH REGISTRAR
GLEBE CARE LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 11
GLEBE CARE LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2023
31 December 2023
- 1 -
2023
2022
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
3
3,517,793
3,543,821
Current assets
Inventories
2,700
2,700
Trade and other receivables
4
246,194
1,781,458
Cash and cash equivalents
99,123
118
348,017
1,784,276
Current liabilities
5
(930,903)
(2,379,739)
Net current liabilities
(582,886)
(595,463)
Total assets less current liabilities
2,934,907
2,948,358
Provisions for liabilities
7
(473,935)
(479,724)
Net assets
2,460,972
2,468,634
Equity
Called up share capital
25,000
25,000
Revaluation reserve
1,525,744
1,538,257
Retained earnings
910,228
905,377
Total equity
2,460,972
2,468,634

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 February 2025 and are signed on its behalf by:
Mrs K Sivananthan
Director
Company Registration No. 01857555
GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
- 2 -
1
Accounting policies
Company information

Glebe Care Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 31/33 Commercial Road, Poole, Dorset, BH14 0HU. The principal place of business is Church Lane, Chaldon, Caterham, Surrey CR3 5AL

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The financial statements of the company are consolidated in the financial statements of Golden Years Ltd. These consolidated financial statements are available from its registered office, 31/33 Commercial Road, Poole, Dorset BH14 0HU.

1.2
Going concern

The directors have adopted the going concern basis in preparing these accounts after assessing the principal risks applicable to the company. These include rising inflation, rising interest rates, staff shortages as a result of Brexit, the increase in the National Living Wage for employees over the age of 21, the cost of living crisis and higher insurance premiums, together with the group's compliance with loan covenants. The directors consider the company to be able to meet its obligations as they fall due for a period of at least 12 months from the date of signing these financial statements, and to be well placed to manage its financing and business risks satisfactorily. Overall, the directors do not consider there to be a cause for material uncertainty regarding the company’s going concern status as at the date of signing these financial statements.

1.3
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the supply of care services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where payments are received from customers in advance of services provided the amounts are recorded as deferred income and included as part of payables due within one year.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred.

1.5
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% straight line on buildings
Fixtures, fittings & equipment
25% reducing balance

Freehold land is not depreciated.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of non-current assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Inventories

Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of inventories over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
1
Accounting policies
(Continued)
- 4 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
42
45
GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 6 -
3
Property, plant and equipment
Freehold land and buildings
Fixtures, fittings & equipment
Total
£
£
£
Cost or valuation
At 1 January 2023
3,802,863
798,928
4,601,791
Additions
-
0
38,709
38,709
At 31 December 2023
3,802,863
837,637
4,640,500
Depreciation and impairment
At 1 January 2023
340,648
717,322
1,057,970
Depreciation charged in the year
38,029
26,708
64,737
At 31 December 2023
378,677
744,030
1,122,707
Carrying amount
At 31 December 2023
3,424,186
93,607
3,517,793
At 31 December 2022
3,462,215
81,606
3,543,821

Property, plant and equipment with a carrying amount of £3,517,793 (2022: £3,543,821) have been pledged to secure liabilities of the company.

GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
3
Property, plant and equipment
(Continued)
- 7 -

The freehold land and buildings were revalued as at 1 January 2014 at open market value (MV1) based on a professional valuation undertaken by Knight Frank RICS of £4.15m on 24 October 2014. The company has taken advantage of the transitional provisions available on the introduction of FRS 102 to carry those assets at that value less depreciation in subsequent years. Subsequent additions to freehold land and buildings are included at cost.

The comparable amounts for land and buildings under the historical cost convention are:

2023
2022
£
£
Cost
1,604,884
1,604,844
Accumulated depreciation
(157,841)
(141,793)
Carrying value
1,447,043
1,463,051
4
Trade and other receivables
2023
2022
Amounts falling due within one year:
£
£
Trade receivables
135,315
145,607
Amounts owed by group undertakings
-
0
40,116
Other receivables
9,381
1,468,924
Prepayments and accrued income
101,498
126,811
246,194
1,781,458

The carrying amount of trade and other receivables includes £246,194 (2022: £1,781,458) pledged as security for liabilities.

5
Current liabilities
2023
2022
£
£
Bank loans and overdrafts
6
-
0
1,429
Other borrowings
6
48,158
1,668,735
Trade payables
63,990
87,511
Corporation tax
392,144
348,629
Other taxation and social security
29,582
25,298
Other payables
212,392
164,425
Accruals and deferred income
184,637
83,712
930,903
2,379,739
GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 8 -
6
Borrowings
2023
2022
£
£
Bank overdrafts
-
0
1,429
Loans from group undertakings and related parties
48,158
1,668,735
48,158
1,670,164
Payable within one year
48,158
1,670,164
7
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2023
2022
Balances:
£
£
Accelerated capital allowances
20,532
16,946
Revaluations
453,403
462,778
473,935
479,724
2023
Movements in the year:
£
Liability at 1 January 2023
479,724
Charge to profit or loss
3,586
Credit to other comprehensive income
(9,375)
Liability at 31 December 2023
473,935

Of the deferred tax liability set out above, an amount of £5,369 is expected to reverse within 12 months and relates to accelerated capital allowances and an amount of £9,375 is expected to reverse within 12 months and relates to revaluation gains.

GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 9 -
8
Retirement benefit schemes
2023
2022
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
23,528
23,470

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

At the year end there were contributions outstanding of £2,105 (2022: £5,122) shown in other creditors and in accruals.

9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

The senior statutory auditor was Michelle Pettifer.
The auditor was Morris Lane.
10
Financial commitments, guarantees and contingent liabilities

At 31 December 2023, the company provided security for the bank borrowings of the parent company, Golden Years Ltd, by way of a first legal mortgage over the freehold property, and a fixed and floating debenture over all the assets of the company. In addition, there is a composite guarantee between all the group companies and also those of Serene LL Ltd, Trinity LL Ltd and Seabrooke Manor LL Ltd limited to £27,000,000 (2022: limited to £27,000,000). As at 31 December 2023, the maximum exposure of the company in respect of the composite guarantee between all parties was £23,165,673 (2022: £25,298,653).

11
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2023
2022
£
£
Within one year
13,979
10,878
Between two and five years
32,475
4,284
In over five years
3,101
-
0
49,555
15,162
GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 10 -
12
Related party transactions
Remuneration of key management personnel
2023
2022
£
£
Aggregate compensation
7,920
8,640

During the year £7,920 (2022: £8,640) was paid by the parent company, Golden Years Ltd, in respect of remuneration of key management of the company.

Transactions with related parties

During the year the company entered into the following transactions with related parties:

The following amounts were outstanding at the reporting end date:

2023
2022
Amounts due to related parties
£
£
Entities with control, joint control or significant influence over the company
5,206
1,176,320
Entities under the common control
-
200
Fellow subsidiary undertakings
42,952
492,215
48,158
1,668,735

These loans are interest free and repayable on demand.

The following amounts were outstanding at the reporting end date:

2023
2022
Amounts due from related parties
£
£
Entities with control, joint control or significant influence over the company
-
40,116
Entities under the common control
-
1,466,674
-
1,506,790

These loans are interest free and repayable on demand.

Other information

During the year, the company received income from its parent company, Golden Years Limited, of £431,708 (2022: £427,712) in respect of care services provided.

 

Further related party information can be found in note 10 and note 13.

GLEBE CARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 11 -
13
Parent company

The ultimate parent company is Golden Years Holdings Ltd, whose registered office is Ordnance House, 31 Pier Road, St. Helier, Jersey.

The ultimate controlling parties are Dr A Sivananthan and Mrs K Sivananthan by virtue of their 100% shareholding in the ultimate parent company, Golden Years Holdings Ltd.

The smallest and largest group into which the company is consolidated is Golden Years Ltd.

2023-12-312023-01-01falsefalsefalse24 February 2025CCH SoftwareCCH Accounts Production 2024.310No description of principal activityDr A SivananthanMrs K Sivananthan018575552023-01-012023-12-31018575552023-12-31018575552022-12-3101857555core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3101857555core:FurnitureFittings2023-12-3101857555core:LandBuildingscore:OwnedOrFreeholdAssets2022-12-3101857555core:FurnitureFittings2022-12-3101857555core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3101857555core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3101857555core:CurrentFinancialInstruments2023-12-3101857555core:CurrentFinancialInstruments2022-12-3101857555core:ShareCapital2023-12-3101857555core:ShareCapital2022-12-3101857555core:RevaluationReserve2023-12-3101857555core:RevaluationReserve2022-12-3101857555core:RetainedEarningsAccumulatedLosses2023-12-3101857555core:RetainedEarningsAccumulatedLosses2022-12-3101857555bus:Director22023-01-012023-12-3101857555core:LandBuildingscore:OwnedOrFreeholdAssets2023-01-012023-12-3101857555core:FurnitureFittings2023-01-012023-12-31018575552022-01-012022-12-3101857555core:LandBuildingscore:OwnedOrFreeholdAssets2022-12-3101857555core:FurnitureFittings2022-12-31018575552022-12-3101857555core:WithinOneYear2023-12-3101857555core:WithinOneYear2022-12-3101857555core:BetweenTwoFiveYears2023-12-3101857555core:BetweenTwoFiveYears2022-12-3101857555core:MoreThanFiveYears2023-12-3101857555core:MoreThanFiveYears2022-12-3101857555core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2023-12-3101857555bus:PrivateLimitedCompanyLtd2023-01-012023-12-3101857555bus:SmallCompaniesRegimeForAccounts2023-01-012023-12-3101857555bus:FRS1022023-01-012023-12-3101857555bus:Audited2023-01-012023-12-3101857555bus:Director12023-01-012023-12-3101857555bus:FullAccounts2023-01-012023-12-31xbrli:purexbrli:sharesiso4217:GBP